In line with the WHO recommendations and guidance issued in April 2020, USAID advised Act | West to temporarily suspend NTD field activities.
FY22 Work Plans for each of Act | West's 11 countries.
The FY22 Work Plan for FHI 360 covers October 1, 2021 - September 30, 2022, the fourth year of the five-year program.
The Global Health Science and Practice Technical Exchange (GHTechX) took place virtually from April 21 - 24, 2021. The event is curated through a partnership between USAID, the George Washington University, and the Global Health: Science and Practice Journal. Our goal is to convene speakers and technical sessions that highlight the latest and greatest in global health, with participants spanning global health experts, students, and professionals from across the global health community.
Cet évènement s’inscrit dans le cadre d’une série de webinaires de renforcement des capacités visant à améliorer les compétences nationales en matière de chaîne d’approvisionnement des programmes de MTN et à créer un espace de partage d’expérience entre pays.
This webinar is part of a series of capacity-building webinars to enhance national NTD program supply chain competences and create space for cross-country experience sharing.
Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.
Les effets indésirables (EI) particulièrement les effets indésirables graves (EIG) associés à l’administration de médicaments de masse ont un impact grave non seulement sur les personnes directement touchées, mais aussi sur la viabilité du programme national de lutte contre les maladies tropicales négligées (MTN) du ministère de la Santé.
The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.
Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19
Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.